1. Lew, MF, Yeung, Y. Parkinson's disease. Reference module in biomedical science. Elsevier; 2014.
Google Scholar2. Wojtala, J, Heber, IA, Neuser, P, et al. Cognitive decline in Parkinson's disease: the impact of the motor phenotype on cognition. J. Neurol, Neurosurg. Psychiatry. 2019;90(2):171-179.
Google Scholar | Crossref | Medline3. Braak, H, Ghebremedhin, E, Rüb, U, Bratzke, H, Del Tredici, K. Stages in the development of Parkinson's disease-related pathology. Cell and Tissue Research. 2004;318(1):121-134.
Google Scholar | Crossref | Medline | ISI4. Aarsland, D, Andersen, K, Larsen, JP, Lolk, A. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch. Neurol. 2003;60(3):387-392.
Google Scholar | Crossref | Medline5. Pedersen, KF, Larsen, JP, Tysnes, OB, Alves, G. Natural course of mild cognitive impairment in Parkinson disease: a 5-year population-based study. Neurol. 2017;88(8):767-774. doi: 10.1212/WNL.0000000000003634
Google Scholar | Crossref | Medline6. Litvan, I, Goldman, J, Tröster, A, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: movement disorder society task force guidelines. Mov. Disord. 2012;27(3):349-356.
Google Scholar | Crossref | Medline | ISI7. Domellöf, ME, Ekman, U, Forsgren, L, Elgh, E. Cognitive function in the early phase of Parkinson's disease, a five-year follow-up. Acta Neurol. Scand. 2015;132(2):79-88. doi: 10.1111/ane.12375
Google Scholar | Crossref | Medline | ISI8. Wood, K-L, Myall, DJ, Livingston, L, et al. Different PD-MCI criteria and risk of dementia in Parkinson's disease: 4-year longitudinal study. NPJ Parkinsons Dis. 2016;2(1):15027. doi: 10.1038/npjparkd.2015.27
Google Scholar | Crossref | Medline9. Hobson, P, Meara, J. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort. Int. J. Geriatr. Psychiatry. 2015;30(10):1048-1055.
Google Scholar | Crossref | Medline10. Jones, JD, Kuhn, TP, Szymkowicz, SM. Reverters from PD-MCI to cognitively intact are at risk for future cognitive impairment: analysis of the PPMI cohort. Parkinsonism & Related Disorders. 2018;47:3-7. https://doi.org/10.1016/j.parkreldis.2017.12.006
Google Scholar | Crossref | Medline11. Doty, R, Hawkes, C, Good, KP, Duda, J. Odor perception and neuropathology in neurodegenerative diseases & schizophrenia. In: The Handbook of Olfaction and Gustation. 3rd (Vol. 3, pp. 403-452) ed. Wiley 2015; 2015.
Google Scholar | Crossref12. Meusel, T, Westermann, B, Fuhr, P, Hummel, T, Welge-Lüssen, A. The course of olfactory deficits in patients with Parkinson's disease—A study based on psychophysical and electrophysiological measures. Neurosci. Lett. 2010;486(3):166-170.
Google Scholar | Crossref | Medline13. Doty, RL, Deems, DA, Stellar, S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurol. 1988;38(8):1237-1244.
Google Scholar | Crossref | Medline14. Braak, H, Bohl, JR, Muller, CM, Rub, U, de Vos, RA, Del Tredici, K. Stanley fahn lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered. Mov Disord. 2006;21(12):2042-2051.
Google Scholar | Crossref | Medline | ISI15. Fullard, ME, Tran, B, Xie, SX, et al. Olfactory impairment predicts cognitive decline in early Parkinson's disease. Parkinsonism Relat. Disord. 2016;25:45-51.
Google Scholar | Crossref | Medline16. Rolheiser, TM, Fulton, HG, Good, KP, et al. Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson's disease. Journal of Neurology. 2011;258(7):1254-1260.
Google Scholar | Crossref | Medline17. Joshi, N, Rolheiser, T, Fisk, M, et al. Lateralized microstructural changes in early-stage Parkinson's disease in anterior olfactory structures, but not in substantia nigra. J. Neurol. 2017;264(7):1497-1505.
Google Scholar | Crossref | Medline18. Hoehn, M, Yahr, M. Parkinsonism: onset, progression and mortality. Neurol. 1967;17(5):427-442.
Google Scholar | Crossref | Medline | ISI19. Wechsler, D . Wechsler abreviated scale of intelligence (WASI) manual. Psychological Corporation; 1999.
Google Scholar20. Woods, SP, Delis, DC, Scott, JC, Kramer, JH, Holdnack, JA. The California verbal learning test--second edition: test-retest reliability, practice effects, and reliable change indices for the standard and alternate forms. Arch. Clin. Neuropsychol. 2006;21 (5):413-420.
Google Scholar | Crossref21. Smith, A . Symbol Digits Modalities Test: Manual. Western Psychological Services; 2007.
Google Scholar22. Delis, DC, Kaplan, E, Kramer, J. Delis Kaplan executive function system. The Psychological Corporation; 2001.
Google Scholar23. Wechsler, D . Wechsler memory scale. 3rd ed. The Psychological Corporation; 1997.
Google Scholar24. Hoops, S, Nazem, S, Siderowf, AD, et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurol. 2009;73(21):1738-1745.
Google Scholar | Crossref | Medline | ISI25. Janvin, CC, Larsen, JP, Aarsland, D, Hugdahl, K. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Movement Disorders: Official Journal of the Mov. Disord. 2006;21(9):1343-1349.
Google Scholar | Crossref | Medline | ISI26. Hugh, S, Siu, J, Hummel, T, et al. Olfactory testing in children using objective tools: comparison of Sniffin Sticks and University of Penn J Otolaryngol Head Neck Surg sylvania smell identification test (UPSIT). J. Otolaryngo.l Head Neck Surg. 2015;44(1):10.
Google Scholar | Crossref27. Doty, RL, Shaman, P, Dann, M. Development of the university of Pennsylvania smell identification test: a standardized microencapsulated test of olfactory function. Physiol. Behav. 1984;32(3):489-502.
Google Scholar | Crossref | Medline | ISI28. Doty, RL, Shaman, P, Kimmelman, C, Dann, M. University of Pennsylvania smell identification test: a rapid quantitative olfactory function test for the clinic. The Laryngoscope. 1984;94(2 Pt 1):176-178.
Google Scholar | Crossref | Medline29. Doty, RL, Newhouse, M, Azzalina, J. Internal consistency and short-term test-retest reliability of the University of Pennsylvania smell identification test. Chem. Senses. 1985;10(3):297-300.
Google Scholar | Crossref30. Smith, SM, Jenkinson, M, Woolrich, MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage. 2004;23(S1):208-219. https://doi.org/10.1016/j.neuroimage.2004.07.051
Google Scholar | Crossref | ISI31. Aarsland, D, Creese, B, Politis, M, et al. Cognitive decline in Parkinson disease. Nat. Rev. Neurol. 2017;13(4):217-231.
Google Scholar | Crossref | Medline32. Berendse, HW, Roos, DS, Raijmakers, P, Doty, RL. Motor and non - motor correlates of olfactory dysfunction in Parkinson's disease. J. Neurol. Sci. 2011;310(1-2):21-24.
Google Scholar | Crossref | Medline33. Alexander, AL, Hurley, SA, Samsonov, AA, et al. Characterization of cerebral white matter properties using quantitative magnetic resonance imaging stains. Brain Connectivity. 2011;1(6):423-446.
Google Scholar | Crossref | Medline34. Alexander, AL, Lee, JE, Lazar, M, Field, AS. Diffusion tensor imaging of the brain. Neurotherapeutics. 2007;4(3):316-329.
Google Scholar | Crossref | Medline | ISI35. Melzer, TR, Watts, R, MacAskill, MR, et al. White matter microstructure deteriorates across cognitive stages in Parkinson disease. Neurol. 2013;80(20):1841-1849.
Google Scholar | Crossref | Medline36. Agosta, F, Canu, E, Stefanova, E, et al. Mild cognitive impairment in Parkinson's disease is associated with a distributed pattern of brain white matter damage. Hum. Brain Mapp. 2014;35(5):1921-1929.
Google Scholar | Crossref | Medline37. Kamagata, K, Motoi, Y, Tomiyama, H, et al. Relationship between cognitive impairment and white-matter alteration in Parkinson's disease with dementia: tract-based spatial statistics and tract-specific analysis. Eur. Radiol. 2013;23(7):1946-1955.
Google Scholar | Crossref | Medline38. Weintraub, D, Doshi, J, Koka, D, et al. Neurodegeneration across stages of cognitive decline in Parkinson disease. Arch. Neurol. 2011;68(12):1562-1568.
Google Scholar | Crossref | Medline39. Jia, X, Wang, Z, Yang, T, et al. Entorhinal Cortex atrophy in early, drug-naive Parkinson's disease with mild cognitive impairment. Aging. Dis. 2019;10(6):1221-1232. https://doi.org/10.14336/AD.2018.1116
Google Scholar | Crossref | Medline40. Hattori, T, Orimo, S, Aoki, S, et al. Cognitive status correlates with white matter alteration in Parkinson's disease. Hum. Brain. Mapp. 2012;33(3):727-739.
Google Scholar | Crossref | Medline | ISI41. Ogihara, H, Kobayashi, M, Nishida, K, Kitano, M, Takeuchi, K. Applicability of the cross-culturally modified University of Pennsylvania smell identification test in a Japanese population. Am. J. Rhinol. Allergy. 2011;25(6):404-410.
Google Scholar | SAGE Journals42. Muirhead, N, Benjamin, E, Saleh, H. Is the University of Pennsylvania smell identification test (UPSIT) valid for the UK population? Otorhinolaryngologist. 2013;6:99-103.
Google Scholar43. Evans, WJ, Cui, L, Starr, A. Olfactory event-related potentials in normal human subjects: effects of age and gender. Electroencephalogr Clin Neurophysiol. 1995;95(4):293-301. doi: 10.1016/0013-4694(95)00055-4. PMID: 8529560.
Google Scholar | Crossref | Medline